- Home
- ROIV vs PNFP Comparison
ROIV vs PNFP Comparison
Compare ROIV & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- PNFP
- Stock Information
- Founded
- ROIV 2014
- PNFP 2000
- Country
- ROIV United Kingdom
- PNFP United States
- Employees
- ROIV N/A
- PNFP N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- PNFP Major Banks
- Sector
- ROIV Health Care
- PNFP Finance
- Exchange
- ROIV Nasdaq
- PNFP Nasdaq
- Market Cap
- ROIV 7.8B
- PNFP 8.1B
- IPO Year
- ROIV N/A
- PNFP N/A
- Fundamental
- Price
- ROIV $10.99
- PNFP $117.83
- Analyst Decision
- ROIV Buy
- PNFP Buy
- Analyst Count
- ROIV 4
- PNFP 13
- Target Price
- ROIV $17.50
- PNFP $124.00
- AVG Volume (30 Days)
- ROIV 7.2M
- PNFP 484.3K
- Earning Date
- ROIV 08-07-2025
- PNFP 07-15-2025
- Dividend Yield
- ROIV N/A
- PNFP 0.82%
- EPS Growth
- ROIV N/A
- PNFP N/A
- EPS
- ROIV N/A
- PNFP 6.16
- Revenue
- ROIV $29,053,000.00
- PNFP $1,668,433,000.00
- Revenue This Year
- ROIV $2.64
- PNFP $27.58
- Revenue Next Year
- ROIV $378.09
- PNFP $11.78
- P/E Ratio
- ROIV N/A
- PNFP $19.13
- Revenue Growth
- ROIV N/A
- PNFP 3.47
- 52 Week Low
- ROIV $8.73
- PNFP $76.75
- 52 Week High
- ROIV $13.06
- PNFP $131.91
- Technical
- Relative Strength Index (RSI)
- ROIV 44.89
- PNFP 72.48
- Support Level
- ROIV $10.83
- PNFP $105.50
- Resistance Level
- ROIV $11.82
- PNFP $110.27
- Average True Range (ATR)
- ROIV 0.32
- PNFP 2.59
- MACD
- ROIV -0.07
- PNFP 1.26
- Stochastic Oscillator
- ROIV 16.75
- PNFP 90.37
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PNFP Pinnacle Financial Partners Inc.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.